RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Apixaban is an Effective Replacement for Conventional Anticoagulation Therapy
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 13
SP 11
OP 12
DO 10.1177/155989771313004
UL http://mdc.sagepub.com/content/13/13/11.abstract
AB Apixaban, an oral factor Xa inhibitor, is noninferior to enoxaparin plus warfarin for the treatment of acute symptomatic proximal deep vein thrombosis and pulmonary embolism, and is associated with significantly less bleeding compared with conventional therapy. Administered in fixed doses, apixaban may simplify the treatment of acute venous thromboembolism. This article presents the results of the Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism [AMPLIFY; NCT00643201].